Report overview
A program for detecting diabetes, generally including fasting plasma glucose test, oral glucose tolerance test, etc.
This report contains market size and forecasts of Diabetes Testing Program in Global, including the following market information:
Global Diabetes Testing Program Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetes Testing Program market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Instruments Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Testing Program include InSphero AG, Abbott Laboratories, American Laboratory Products Company (ALPCO), Beckmann Coulter Inc., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG and PTS Diagnostics. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Testing Program companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Testing Program Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Testing Program Market Segment Percentages, by Type, 2021 (%)
Instruments
Testing Kits
Reagent
Global Diabetes Testing Program Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Testing Program Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Diagnostic Centers
Home Care Settings
Academic Research Institutes
Global Diabetes Testing Program Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetes Testing Program Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Testing Program revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetes Testing Program revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
InSphero AG
Abbott Laboratories
American Laboratory Products Company (ALPCO)
Beckmann Coulter Inc.
Bio-Rad Laboratories Inc.
Ortho Clinical Diagnostics Inc.
F. Hoffmann-la Roche Ltd
Siemens AG
PTS Diagnostics
